Safety and immunogenicity of a BPL-inactivated, whole-virus, universal influenza vaccine: a randomized, double-blinded, double-dummy, placebo-controlled, phase 1 clinical trial
Nature has shared only the headline of this report so far. The full story, with all its details, is on Nature’s own website.
Read the full report on Nature
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Nature
- Published
- Monday, 12 October 2026, 10:44 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Nature with a short summary and a link to the original. The original reporting belongs to the publisher. Spotted an error in our summary? Tell our corrections desk.